Use intelligence and smart solutions to accelerate access.

Remove barriers to implementing access solutions—make healthcare more efficient and affordable with Lyfegen’s integrated solutions.

Learn more

Trusted by Payers and Pharma around the globe

real-world public access agreements in the library
models and their real-world applications described
drugs with agreements across 33 countries
countries covered


How Lyfegen helps transform
the healthcare of tomorrow

Barriers to implementing innovative contracting agreements slow patient access.

- Conducting research is time-intensive and expensive.
- Drug-specific models are not reusable and simulating real-world scenarios can be challenging.
- Negotiations stall when payers are hesitant to adopt complex solutions.
- Data privacy and security challenges slow adoption of agreements.

An easy, secure and compliant solution to facilitate implementation of value-based contracting.

Lyfegen solutions are used by health insurances, governments, hospital payers, and pharmaceutical companies around the globe to speed up the due diligence process, streamline collaborative drug contract design, and reduce the administrative burden of managing contracting.

Implementing contracting solutions is overwhelming.  

- Manual process of identifying, calculating and claiming rebates is time and resource intensive.
- Challenging to ensure rebate and contract compliance.
- Refunds are missed reducing financial performance.
- Contracts are saved in different locations adding to the administrative burden.

Reduce administrative burden and claim every rebate.

Lyfegen solutions are trusted by health insurances, governments and hospital payers around the globe. Our easy-to-implement rebate management solutions ensure efficient rebate compliance so that you can reduce administrative tasks and focus your time and effort where it is most impactful.

Learn more


Comprehensive knowledge at your fingertips


Negotiate better and faster


Rebate validation and analysis

Customer success stories

I like having a palette of contracts that fall under different domains, like disease state, the way the drug is administered, or available evidence. There are different ways to make a contract attractive to us, to pharma, and to our physicians.

Bernie Good

Senior Medical Director Center for Value Based Pharmacy Initiatives at UPMC Health Plan

Get to know
the team

We are venture-backed, global, and independent Software-as-a-Service provider delivering innovative access, pricing, and rebate solutions to industry players, advancing affordability and access in healthcare. Discover more about Lyfegen and meet the winning team.

Learn more

Interested to learn more? Book a demo.

Get in touch today.

We will respond within the next 24 hours.

* By sending this message, you agree to our privacy policy.


Everything you need to know
about drug access, pricing & rebates

Driving Growth: Welcoming Our New VP of Sales & Business Development, Simon Farrow

Learn more

Value-based pricing vs best price? Medicaid's best price problem

Learn more

Value-based drug agreements are easier when drug manufacturers and payers follow FDA communication guidelines

Learn more

U.S. Department of Health and Human Services’ Innovation Center Revamps Value-Based Payment Models

Learn more

The Effect of Value-Based Drug Pricing on Patient Health Outcomes: More of what’s needed—Efficacy, Access, and Affordability

Learn more

The importance of working with Johnson & Johnson: An interview with our Lyfegen CEO & Founder, Girisha Fernando

Learn more
Discover all insights
Book a Demo